Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7132691 | 0.88 | OPRM1 (0.51) | KDM4EALDH1A1HPGDOPRM1OPRD1 | |
| SCHEMBL29442429 | 0.88 | FKBP4 (0.48) | KDM4EALDH1A1HPGDOPRM1OPRD1 | |
| SCHEMBL2967595 | 0.86 | RAB9A (0.52) | KDM4EALDH1A1HPGDRAB9ATDP1 | |
| SCHEMBL615204 | 0.84 | TDP1 (0.41) | KDM4EALDH1A1HPGDOPRM1OPRD1 | |
| SCHEMBL29543702 | 0.82 | FKBP4 (0.47) | KDM4EALDH1A1HPGDOPRM1OPRD1 | |
| SCHEMBL410223 | 0.81 | FKBP4 (0.54) | CMA1 | |
| SCHEMBL1289940 | 0.81 | CMA1 (0.54) | CMA1 | |
| SCHEMBL3325560 | 0.80 | TACR1 (0.43) | OPRM1OPRD1OPRK1CMA1 | |
| SCHEMBL30070746 | 0.80 | KDM4E (0.50) | KDM4EALDH1A1HPGDOPRM1OPRD1 | |
| SCHEMBL29442434 | 0.79 | KDM4E (0.43) | KDM4EALDH1A1HPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114685472-B | Polysubstituted uracil derivative and use thereof | 广东东阳光药业股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20230047207-A1 | Self-Contained Biological Indicator with Salt Compound | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-02-16 | — | — | US | disclosed |
| CN-114981399-A | Self-contained biological indicator with salt compound | 3M创新有限公司 | 2022-08-30 | — | — | CN | disclosed |
| WO-2022135502-A1 | MULTI-SUBSTITUTED URACIL DERIVATIVE AND USE THEREOF | 广东东阳光药业有限公司 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022135514-A1 | MULTI-SUBSTITUTED URACIL DERIVATIVES AND USE THEREOF | 广东东阳光药业有限公司 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022135534-A1 | SUBSTITUTED NITROGEN-CONTAINING BICYCLIC COMPOUND AND USE THEREOF | 广东东阳光药业有限公司 | 2022-06-30 | — | — | WO | disclosed |
| WO-2021148909-A1 | SELF-CONTAINED BIOLOGICAL INDICATOR WITH SALT COMPOUND | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-07-29 | — | — | WO | disclosed |
| CN-112437676-A | Self-contained biological indicator | 3M创新有限公司 | 2021-03-02 | — | — | CN | disclosed |
| US-7741344-B2 | Process for preparing purified S-BEL and R-BEL and compositions thereof | WASHINGTON UNIVERSITY IN ST. LOUIS (US) | 2010-06-22 | — | — | US | disclosed |
| US-20050181496-A1 | Process for preparing purified s-bel and r-bel and compositions thereof | WASHINGTON UNIVERSITY | 2005-08-18 | — | — | US | disclosed |
| WO-2003079996-A2 | PROCESS FOR PREPARING PURIFIED S-BEL AND R-BEL AND COMPOSITIONS THEREOF | WASHINGTON UNIVERSITY IN ST. LOUIS (US) | 2003-10-02 | — | — | WO | disclosed |